Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Endocrinology · Primary Aldosteronism

Could PET Imaging Replace AVS for Primary Aldosteronism?

At a Glance

68Ga-Pentixafor PET/CT is a promising catheter-free option for identifying one overactive adrenal gland in primary aldosteronism, but it is still investigational. AVS remains the standard before surgery, while medication or repeat AVS may be options if the procedure is not possible.

Yes, there are emerging non-invasive alternatives to adrenal vein sampling (AVS), such as 68Ga-Pentixafor PET/CT scans [1]. However, AVS remains the accepted medical standard to determine which adrenal gland is overproducing aldosterone when planning for surgery [2][3]. Specialized PET scans are considered investigational or complementary tools that may be available at certain expert centers, usually when AVS is unsuccessful or not feasible [4][5].

If you are worried about having AVS, you are not alone. Many patients find the prospect of an invasive catheter procedure intimidating [6]. Here is what you need to know about why AVS is usually required, what the procedure entails, and the current clinical status of non-invasive alternatives.

Why Standard CT or MRI Scans Are Not Enough

When you are diagnosed with primary aldosteronism, your doctor will usually order a standard CT scan (or sometimes an MRI) of your abdomen to assess the anatomy of your adrenal glands and rule out large masses [2]. While important, these scans cannot reliably tell your care team which gland is actually causing the problem.

Standard imaging shows anatomy, not function [7]. A CT scan might show a nodule on your left adrenal gland, but that nodule could be completely harmless and non-functioning, while your normal-looking right gland is actually the one overproducing aldosterone [8]. Conversely, both glands might look entirely normal on a scan even though one is severely overactive [9]. Because relying on standard imaging alone has a high rate of both false-positive and false-negative results, AVS is usually needed to measure the actual hormone output directly from the veins of each gland [7][2].

What to Expect from AVS

AVS is an invasive procedure, but understanding it can help reduce anxiety. It is usually performed by an interventional radiologist who numbs the groin area with local anesthetic and inserts a small catheter into a vein. Using X-ray guidance, they carefully navigate the catheter to the veins draining each adrenal gland to draw blood samples [10]. The most common risks are minor bruising at the catheter insertion site, with very rare but serious risks including injury or rupture of the adrenal vein [11].

Sedation options vary widely by center and should be discussed with your care team beforehand to ensure they choose an approach that keeps you comfortable but does not interfere with the hormone results [6].

The Investigational Role of Specialized PET Scans

To bridge the gap between standard imaging and AVS, researchers have developed specialized PET/CT scans [1]. The most studied is the 68Ga-Pentixafor PET/CT scan.

Unlike AVS, which directly measures hormone levels, this PET scan uses an intravenous radioactive tracer that targets a specific receptor (CXCR4) often found on overactive adrenal cells [12]. While generally well-tolerated, it is a medical procedure that involves an IV injection, waiting time, and exposure to ionizing radiation from the tracer and the CT scan [13].

  • High Predictive Value When Positive: When a 68Ga-Pentixafor PET scan clearly shows strong tracer uptake in only one gland, it can provide a strong indirect signal. In one cohort study of 82 surgical patients, a clearly unilateral PET result had a 98.2% positive predictive value compared to AVS [14].
  • Limitations When Negative: The main drawback is that a negative or ambiguous PET scan does not definitively rule out single-gland disease. In that same 82-patient study, 26 patients (nearly a third) who were proven by AVS to have unilateral disease had a negative or bilateral PET scan [14].

Because of this limitation and the fact that the tracer does not measure aldosterone directly, 68Ga-Pentixafor PET/CT is not a routine replacement for AVS [4]. Other experimental PET tracers, such as 11C-metomidate, also show promise but have variable performance and are highly restricted to a few specialized research facilities [15][16].

When Might AVS Be Skipped?

In very specific situations, medical guidelines suggest AVS might be omitted and a patient can proceed directly to surgery. This exception is generally considered only for patients who are excellent surgical candidates and meet all of the following narrow criteria:

  • Younger age (typically under 35 years old) [17]
  • Spontaneous hypokalemia (low potassium without taking diuretics) [18]
  • Marked aldosterone excess [18][19]
  • A clear, unilateral adrenal adenoma (nodule) on a CT scan, with a completely normal-appearing gland on the other side [17]

Even in these cases, there is a small risk of the imaging misleading the surgical plan, so this decision requires careful, individualized discussion with a specialist [20].

Alternatives If You Decline AVS or It Is Unsuccessful

If you decide against AVS, or if the procedure is attempted but the radiologist cannot successfully draw blood from both veins (which happens occasionally), you are not out of options [10].

Depending on your overall health and goals, your team may recommend:

  1. Pursuing Medical Management: Surgery is not mandatory for primary aldosteronism. You can opt for medical therapy using mineralocorticoid-receptor antagonists (like spironolactone or eplerenone) to block the effects of aldosterone, which is the standard, effective treatment for patients who do not want surgery, who are not surgical candidates, or who have bilateral disease [2].
  2. Repeating the AVS at a high-volume specialized center with a very experienced interventional radiologist [21].

Common questions in this guide

What non-invasive alternatives to AVS are available for primary aldosteronism?
The main emerging catheter-free option is 68Ga-Pentixafor PET/CT, which uses an injected tracer and CT imaging rather than catheters in the adrenal veins. It can provide indirect information about which gland may be overactive, but it is investigational and AVS remains the standard when surgery is planned.
Can a CT or MRI scan show which adrenal gland is causing primary aldosteronism?
Usually not. CT and MRI show the size and appearance of the adrenal glands, but they do not directly measure aldosterone production, so a visible nodule may be nonfunctioning or both glands may look normal.
How reliable is 68Ga-Pentixafor PET/CT compared with AVS?
A clearly one-sided PET result can be a strong indirect sign of one-gland disease, but a negative or two-sided result does not reliably exclude it. Because the scan does not measure aldosterone directly, it is not a routine replacement for AVS.
When can someone have adrenal surgery without AVS?
Guidelines may allow AVS to be skipped in a narrow group, usually people younger than 35 with spontaneous low potassium, marked aldosterone excess, a clear one-sided adrenal adenoma on CT, and a normal-looking opposite gland. The decision should be individualized with a specialist because imaging can still misidentify the source.
What can I do if I decline AVS or the procedure is unsuccessful?
Primary aldosteronism can often be managed with an aldosterone-blocking medicine called a mineralocorticoid-receptor antagonist, such as spironolactone or eplerenone, especially when surgery is not wanted or appropriate. Another option is repeating AVS at a high-volume center with an experienced interventional radiologist.
What does AVS involve, and what are its main risks?
An interventional radiologist uses local anesthetic and X-ray guidance to place a small catheter through a groin vein and collect blood from the adrenal veins. Bruising at the insertion site is the most common risk, while serious adrenal-vein injury or rupture is very rare; sedation options should be discussed because they must not interfere with hormone results.

Get notified when new evidence is published on hyperaldosteronism.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Performance of Pentixafor PET/CT in identifying unilateral primary aldosteronism: A meta-analysis.

    Gege Z, Ling Z, Bin J

    European journal of radiology 2025; (190()):112240 doi:10.1016/j.ejrad.2025.112240.

    PMID: 40543282
  2. 2

    The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

    Funder JW, Carey RM, Mantero F, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(5)):1889-916 doi:10.1210/jc.2015-4061.

    PMID: 26934393
  3. 3

    Subtyping of Primary Aldosteronism by Adrenal Venous Sampling.

    Rossi GP, Battistel M, Seccia TM, et al.

    Endocrine reviews 2025; (46(4)):501-517 doi:10.1210/endrev/bnaf007.

    PMID: 39965116
  4. 4

    Agreement Between Molecular Imaging and Adrenal Vein Sampling for Localization in Primary Aldosteronism: A Systematic Review.

    Glassman IB, Fremont D, Retta A, et al.

    Journal of the American Heart Association 2026; (15(11)):e049366 doi:10.1161/JAHA.126.049366.

    PMID: 42216268
  5. 5

    AVS-referenced diagnostic performance of 68Ga-Pentixafor PET/CT for detecting unilateral disease in primary aldosteronism: a systematic review and meta-analysis.

    Su J, Chi C, Wang S, et al.

    Frontiers in endocrinology 2026; (17()):1777128 doi:10.3389/fendo.2026.1777128.

    PMID: 42687933
  6. 6

    Identification of Aldosterone-Producing Adrenal Adenomas Using [68Ga]Ga-Pentixafor PET/CT in an Australian Cohort.

    Ng E, Jong I, Lau KK, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2026; (67(4)):606-614 doi:10.2967/jnumed.125.271006.

    PMID: 41611475
  7. 7

    Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis.

    Zhou Y, Wang D, Jiang L, et al.

    BMJ open 2020; (10(12)):e038489 doi:10.1136/bmjopen-2020-038489.

    PMID: 33384386
  8. 8

    Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.

    Ladurner R, Sommerey S, Buechner S, et al.

    European journal of clinical investigation 2017; (47(5)):372-377 doi:10.1111/eci.12746.

    PMID: 28299775
  9. 9

    Diagnostic consistency between computed tomography and adrenal vein sampling of primary aldosteronism: leading to successful curative outcome after adrenalectomy; a retrospective study.

    Kim BC, Yoon HK, Park KJ, et al.

    International journal of surgery (London, England) 2024; (110(2)):839-846 doi:10.1097/JS9.0000000000000850.

    PMID: 37916935
  10. 10

    Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures.

    Jakobsson H, Farmaki K, Sakinis A, et al.

    Diagnostic and interventional radiology (Ankara, Turkey) 2018; (24(2)):89-93 doi:10.5152/dir.2018.17397.

    PMID: 29467114
  11. 11

    Computed tomography image fusion, Coaxial guidewire technique, Fast intraprocedural cortisol testing technique improves success rate and decreases radiation exposure, procedure time, and contrast use for adrenal vein sampling.

    Liu Z, He M, Song X, et al.

    Journal of hypertension 2021; (39(9)):1918-1925 doi:10.1097/HJH.0000000000002852.

    PMID: 34039913
  12. 12

    The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism.

    Peng Y, Chen F, Yao R, et al.

    Frontiers in endocrinology 2025; (16()):1533295 doi:10.3389/fendo.2025.1533295.

    PMID: 40084145
  13. 13

    Real world experience with [68Ga]PentixaFor PET/CT in Primary Aldosteronism using newly developed harmonized diagnostic criteria.

    Hesse L, Herden A, MacFarlane J, et al.

    Frontiers in endocrinology 2026; (17()):1787233 doi:10.3389/fendo.2026.1787233.

    PMID: 41852469
  14. 14

    KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery.

    Wang Z, Luo J, Guan L, et al.

    The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag301.

    PMID: 42531454
  15. 15

    Molecular Imaging Versus Adrenal Vein Sampling for the Detection of Surgically Curable Primary Aldosteronism : A Prospective Within-Patient Trial.

    Goodchild E, Wu X, Senanayake R, et al.

    Annals of internal medicine 2025; (178(3)):336-347 doi:10.7326/ANNALS-24-00761.

    PMID: 40030172
  16. 16

    Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

    Soinio M, Luukkonen AK, Seppänen M, et al.

    European journal of endocrinology 2020; (183(6)):539-550.

    PMID: 33055298
  17. 17

    Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.

    Umakoshi H, Ogasawara T, Takeda Y, et al.

    Clinical endocrinology 2018; (88(5)):645-651 doi:10.1111/cen.13582.

    PMID: 29464741
  18. 18

    Identifying unilateral aldosterone-producing adenomas using published algorithms and imaging: a systematic review and meta-analysis.

    Ng E, Gwini SM, Zheng W, et al.

    Endocrine connections 2025; (14(11)).

    PMID: 41066498
  19. 19

    Adrenal Venous Sampling in Young Patients with Primary Aldosteronism. Extravagance or Irreplaceable?

    Gkaniatsa E, Sakinis A, Palmér M, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(5)):e2087-e2095 doi:10.1210/clinem/dgab047.

    PMID: 33507307
  20. 20

    Adrenal Vein Sampling in the Young - Necessary or Not?

    Gkaniatsa E, Ragnarsson O

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2023; (131(7-08)):435-437 doi:10.1055/a-2099-3525.

    PMID: 37225137
  21. 21

    Success Rate of Adrenal Venous Sampling and its Determining Factors: Experience of a Single Center in Malaysia.

    Muhamad Pauzi KN, Zakaria R, Leong YY, et al.

    Annals of vascular surgery 2024; (98()):258-267 doi:10.1016/j.avsg.2023.08.021.

    PMID: 37820987

This page explains alternatives to adrenal vein sampling for primary aldosteronism for informational purposes only and does not constitute medical advice. Discuss imaging, AVS, and treatment choices with your endocrinologist and care team.